Status:
UNKNOWN
Telemedicine in Age-Related Macular Degeneration
Lead Sponsor:
The New York Eye & Ear Infirmary
Collaborating Sponsors:
iHealthScreen Inc
Conditions:
Age Related Macular Degeneration
Eligibility:
All Genders
50+ years
Brief Summary
This study seeks to evaluate a system for the automated early detection of Age-Related Macular Degeneration (AMD). AMD is a condition in which there is breakdown of the macula of the eye, the part of ...
Detailed Description
iPredict,an AI and telemedicine based software which used individual's color fundus image for early diagnosis of AMD and predict if an individual is at risk of progression to late AMD. iPredict platfo...
Eligibility Criteria
Inclusion
- Subjects will be recruited if willing and able to comply with clinic visit and study-related procedures, and provide signed informed consent
- Gender of Subjects: Both males and females will be invited to participate.
- Age of Subjects: Patients will be over 50 years and older
Exclusion
- Unable to provide informed consent.
- Other retinal degenerations and retinal vascular diseases such as diabetic retinopathy or macular edema, prior retinal surgery.
Key Trial Info
Start Date :
July 19 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04863391
Start Date
July 19 2020
End Date
December 31 2022
Last Update
April 28 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
New York Eye and Ear Infirmary of Mount Sinai
New York, New York, United States, 10003